Krebs Stimulator Plus (Apotheca Company)


Welcome to the PulseAid listing for the Krebs Stimulator Plus drug offered from Apotheca Company. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Apotheca Company
NON-PROPRIETARY NAME: Tabebuia impetiginosa, Uncaria tomentosa, Hypothalamus, Pituitary, Glandula suprarenalis, Nadidum, Lacticum acidum,
SUBSTANCE NAME: TABEBUIA IMPETIGINOSA BARK; CAT'S CLAW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PITUITARY GLAND; SUS SCROFA ADRENAL GLAND; NADIDE; LACTIC ACID, DL-; LACTIC ACID, L-; COENZYME A; ADENOSINE TRIPHOSPHATE; BI
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2010-03-25
END MARKETING DATE: 0000-00-00


Krebs Stimulator Plus HUMAN OTC DRUG Details:

Item DescriptionKrebs Stimulator Plus from Apotheca Company
LABELER NAME: Apotheca Company
DEA SCHEDULE:
ACTIVE STRENGTH: 3; 3; 6; 200; 60; 12; 30; 30; 30; 30; 8; 200([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2010-03-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 57520-0217_10514191-5382-4ba8-9694-40ccf8e16760
PRODUCT NDC: 57520-0217
APPLICATION NUMBER:

Other TABEBUIA IMPETIGINOSA BARK; CAT'S CLAW; SUS SCROFA HYPOTHALAMUS; SUS SCROFA PITUITARY GLAND; SUS SCROFA ADRENAL GLAND; NADIDE; LACTIC ACID, DL-; LACTIC ACID, L-; COENZYME A; ADENOSINE TRIPHOSPHATE; BI Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name